Gossamer Bio, Inc. GOSS
- seralutinib — Pulmonary Arterial Hypertension Phase 3
- seralutinib — Pulmonary Hypertension associated with Interstitial Lung Disease Phase 3
CSF-1R (2 companies · 3 programs)
Companies with an active program directed at CSF-1R.
Adagene Inc. ADAG
- ADG125 Phase 2